In recent years the emergence of methicillin-resistant *Staphylococcus aureus* (MRSA) sequence type 398 (ST398), known as live-stock-associated MRSA (LA-MRSA) has attracted particular attention. This is due to its association with pigs and pig farming and its ability to colonize or infect people, such as farmers, who work in close contact with these animals \[[@ref1], [@ref2]\]. Less frequently MRSA ST398 has been found in a variety of other farm animals, such as horses, poultry, or cattle and from foods of animal origin. Although inter-human transmission has been described, the incidence of MRSA ST398, especially in hospitals, appears to be much lower than for other MRSA genotypes \[[@ref1]\].

MRSA ST398 usually lacks the virulence determinants that are typically found in hospital-acquired MRSA or community-acquired MRSA. The majority of analysed MRSA ST398 isolates carried haemolysin-encoding genes, only a small number of isolates carried the bicomponent leukotoxin Panton--Valentine (*lukPV*) genes or staphylococcal enterotoxins (SE; *se* genes). Genes for other toxins, i.e. exfoliative toxins (ET), leukocidins or toxic shock syndrome toxins (TSST-1) have not as yet been reported in MRSA ST398 isolates \[[@ref3], [@ref4]\].

Phenotypically, MRSA ST398 is resistant to oxacillin and all β-lactam antibiotics. Resistance to tetracycline is also very common due to its frequent use in pig and cattle farming \[[@ref5]\]. Resistance to other antibiotics, especially erythromycin, clindamycin, aminoglycosides or trimethoprim/sulfamethoxazole has been reported; however, multi-resistance to ⩾3 antimicrobial groups is uncommon \[[@ref1], [@ref3]\].

In Austria intensive pig farming with about 1·2 million pigs is concentrated in two regions (north and south-east) which are served by two microbiological laboratories and these account for practically all human MRSA ST398 isolates reported in Austria \[[@ref2], [@ref6]\].

The aim of this study was to determine whether the virulence and antimicrobial resistance gene profiles of MRSA ST398 in human isolates in Austria differ between the two regions or whether animal trading throughout the country resulted in the spread of identical MRSA ST398 clones.

From January 2004 to December 2008, 41 MRSA ST398 isolates were identified from a total of about 1900 MRSA human primary isolates, from routine samples at two microbiological laboratories in Austria (27 from Linz, 14 from Graz). As published previously, contact with animals (predominantly pigs and/or cows, and horses or hens only) was documented in 32 patients. Clinical manifestations ranged from solely colonization to purulent infections including a case of complicated osteomyelitis. The number of MRSA ST398 detected per year increased steadily from one isolate in 2004 to 16 in 2008 \[[@ref2], [@ref6]\].

All MRSA ST398 isolates were retested for susceptibility to the following antimicrobial agents: oxacillin, tetracycline, erythromycin, clindamycin, gentamicin, trimethoprim/sulfamethoxazole, quinupristin/dalfopristin, fusidic acid, daptomycin, rifampicin, linezolid, vancomycin, and chloramphenicol by E-tests (bioMérieux, France) according to the guidelines of the Clinical and Laboratory Standards Institute (CLSI) \[[@ref7]\]. Isolates were also further characterized by *spa* typing, multilocus sequence typing (MLST) and SCC*mec* typing as described previously \[[@ref6]\].

Identibac MRSA bacterial genotyping system (Identibac, UK; StaphyType, Alere Technologies GmbH, Germany) was used to characterize the isolates, according to the manufacturer\'s instructions and recently published recommendations \[[@ref8]\]. This DNA microarray comprises 334 target sequences, which correspond to 171 distinct genes and their allelic variants, including *S*. *aureus* specific genes, accessory gene regulator (*agr*) alleles and genes coding for virulence factors (toxins, enterotoxins, haemolysins, proteases, biofilm formation molecules). Hybridization patterns were analysed using Splits Tree4 software ([www.splitstree.org](www.splitstree.org)), designed to compute unrooted phylogenetic networks from molecular sequence data. Gene profiles were converted to 'sequence-like' strings of information, defining present genes as 'A' (positive), absent genes as 'T' (negative) and spots with ambiguous signal intensities as missing \[[@ref9]\].

*Spa* typing of the 41 MRSA ST398 isolates assigned 36 to *spa* type t011, two each to t034 and t2346, and one to t1451. Types t011 and t034 were found in both the north and south-east of Austria whereas t2346 was confined to the north; the t1451 isolate originated in the south-east. All, but one, of the isolates were of SCC*mec* type V and the outlier (t034) was of SCC*mec* type IV. All isolates were of *agr* type I.

As expected resistance to oxacillin was universal but 13 (31·7%) isolates exhibited a multidrug resistance phenotype with resistance to ⩾3 classes of antimicrobial agents. All but one isolate were resistant to tetracycline and 13 expressed constitutive erythromycin-clindamycin resistance (cMLS~B~); three isolates were resistant to gentamicin and one to chloramphenicol. The single tetracycline-susceptible isolate was of type t034 and originated from northern Austria.

None of the isolates exhibited resistance to trimethoprim/sulfamethoxazole, quinupristin/dalfopristin, fusidic acid, daptomycin, rifampicin, linezolid, and vancomycin.

Determination of the resistance gene profiles using the DNA microarray demonstrated concordant results with susceptibility data. All isolates were positive for the *mecA* gene and 40 harboured the ampicillin-penicillin resistance gene *blaZ* and the tetracycline resistance gene *tetM*; 28 isolates carried the *tetK* gene. Regarding genes involved in resistance to eryth romycin-clindamycin (MLS~B~), *ermC* was detected in 13 isolates, which was in agreement with phenotypic resistance patterns but *ermA* and *ermB* were not identified in any of the isolates and none harboured other macrolide resistance genes *msrA*, *mefA*, *mpbBM* and the clindamycin resistance gene *linA*. Three isolates carried the streptogramin resistance gene *vga*, two isolates the aminoglycoside resistance genes *aacA-aphD* and one was positive for *flexA* (conferring resistance to chloramphenicol). A single isolate carried the *mecA* gene only and no further resistance genes.

All 41 isolates were negative for genes encoding PVL (*lukS-PVL*, *lukF-PVL*), enterotoxins (*ent* genes), and the toxic shock syndrome toxin (*tst-1*). By contrast all isolates were positive for genes encoding leukocidins (*lukF* and *lukS* as part of the *hlg* locus), haemolysins (*hl*, *hld*, *hlIII*), aureolysin (*aur*), glutamyl endopeptidase/V8-protease (*sspA*) and staphopain A (*sspP*). The frequency of other genes was as follows: leukocidin genes *lukX* in 40 and *lukY* in 36 (87·8%) isolates, the haemolysin genes *hlgA* in 39 (95·1%), and *hla* in 32 (78·0%) isolates, and the staphopain B gene *sspB* in 39 (95·1%) isolates. The *sak* gene encoding staphylokinase in combination with *scn* encoding a staphylococcal complement inhibitor was detected in four (9·8%) isolates, *chp* (CHIPS) gene coding for chemotaxis inhibitory protein in three (7·3%) and the *arcD-SCC* gene coding for arginine/ornithine antiporter in only a single (2·4%) isolate. Twenty-nine (70·7%) isolates demonstrated highly similar virulence gene profiles including the leukocidin genes (*lukF*, *lukS*, *lukX*, *lukY*), haemolysin genes (*hlgA*, *hl*, *hla*, *hld*, *hlIII*), aureolysin gene (*aur*), glutamyl endopeptidase/V8-protease gene (*sspA*), staphopain B gene (*sspB*), and staphopain A gene (*sspP*). Other gene profiles were represented by one or two isolates.

SplitsTree analysis was used for calculation of an unrooted phylogenetic network depicting strain relatedness, using the data on presence/absence of genes generated by DNA microarray. Except for one strain of *spa* type t034, all isolates showed highly similar gene patterns suggesting they were closely related (see [Fig. 1](#fig01){ref-type="fig"}). Besides several minor clusters, one major cluster comprised eight of the 14 MRSA ST398 isolates from the south-east and two from the north of Austria. Four isolates exhibited identical gene profiles indicative of the same strain ([Fig. 1](#fig01){ref-type="fig"}). The analysis did not result in a clear separation of isolates from the two geographical regions but some time-dependent genetic changes were evident as 9/10 isolates recovered from 2004 to 2006 clustered very closely together, while those from 2007 and 2008 showed greater genetic variations, depicted in increased distance in SplitsTree. Fig. 1.\[*colour online*\]. SplitsTree visualizing the similarity among gene profiles obtained by DNA microarray analysis of 41 human isolates of MRSA ST398 in Austria (2004--2008). (*a*) Overview over the full SplitsTree depicting all 41 isolates. (*b*) Detail zooming in on the region depicting the 40 highly similar MRSA ST398 isolates, while omitting atypical isolate LA-MRSA_sA9. Among minor clusters, one major cluster containing almost exclusively strains isolated from the south of Austria was found.

In accordance with previous studies, resistance to tetracycline was almost universal among the isolates and related to the presence of the *tetM* gene \[[@ref3]\], although two-thirds of the isolates also carried the *tetK* gene. The finding of more than one *tet* gene might be explained by the high antibiotic pressure exerted by the widespread use of tetracycline in animal farming \[[@ref5]\]. The absence of *ermA* or *ermB* encoding MLS~B~ resistance in the isolates is in contrast to the predominance of *ermA* in oxacillin-susceptible *S. aureus*. It has been also suggested that *ermB* is more common in staphylococci from animal sources compared to human sources, but this could not be confirmed by our study \[[@ref10]\]. The finding of a single chloramphenicol-resistant isolate in this series corroborates the reported rarity of the *fexA* gene in MRSA ST398 \[[@ref3]\].

Multi-resistance was found in 31·7% of isolates and this rate may be considered low compared to reports from other countries \[[@ref3], [@ref11]\]. However, the absence of resistance to ciprofloxacin or trimethoprim/sulfamethoxazole among the isolates contrasts with the reported resistance rates from Germany of 8% for ciprofloxacin and 4% for trimethoprim/sulfamethoxazole \[[@ref1], [@ref3]\]. Overall, resistance gene patterns were more homogeneous in isolates from south-eastern Austria than those from northern Austria, as some resistance genes (*vga*, *aacA-aphA*, *fexA*) were only detected in strains from northern Austria.

As described previously, the tested MRSA ST398 isolates lacked genes encoding several clinically important *S. aureus*-associated virulence factors such as PVL, toxic shock syndrome toxin, exfoliative toxins, or enterotoxins \[[@ref3], [@ref8]\]. This is consistent with the fact that clinical diseases in humans due to this genotype are rarely observed \[[@ref1]\]. While all isolates were positive for *lukS* and *lukF*, no other leukocidin genes, such as *lukM*, *lukD*, and *lukE* were present. Nevertheless, the first isolates of MRSA ST398 harbouring the *PVL* gene have been described recently in the literature \[[@ref12]\] and there is therefore a need for continuous surveillance as acquisition of this virulence trait could have a significant impact on the disease potential of the genotype.

Notably the two MRSA ST398 isolates of *spa* type t034 differed particularly from others in the series as one of these exhibited the highest number of virulence genes and was susceptible to tetracycline, which is rather uncommon in MRSA \[[@ref3]\]. By contrast, the second t034 isolate had fewer virulence genes than all other isolates and also lacked *lukX* and *lukY*. While the lack of *lukX* in *S. aureus*, including MRSA, has been described before \[[@ref11]\], the absence of *lukY* has not, to our knowledge, been reported. The second isolate was also the only representative from south-eastern Austria to demonstrate resistance to tetracycline and erythromycin-clindamycin. The Splits Tree analysis showed that this strain clustered separately from the rest and epidemiological investigation of animal contact and clinical background of the patient did not provide an explanation for the orign of this strain.

There are two main limitations of this study. First, comparison of MRSA ST398 obtained from human and animal sources within the same time frame was not possible, as screening of animals in Austria did not begin before 2008 \[[@ref5]\]; second, the number of included human samples is limited, due to the rarity of this genotype in humans in Austria \[[@ref2], [@ref6]\].

To summarize, virulence and resistance gene profiles in Austrian MRSA ST398 appear at the moment to be largely uniform, with only few variations beginning in 2007. Our results support the hypothesis that the MRSA ST398 isolates in Austria may have originated from a single clone that was spread throughout the country by animal trading \[[@ref13]\]. Up to now the input of new MRSA ST398 clones appears to be a rare event. The data obtained facilitate worldwide comparison of the virulence gene and antimicrobial resistance properties of this genotype; due to the already described occurrence of the *PVL* gene in MRSA ST398 continuous surveillance is needed to monitor a possible shift to a more virulent or more resistant form.
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